Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Neoplasms 1Lung Neoplasms 1

Interventions

Drug Therapy 107Cisplatin 98Radiotherapy 89Carboplatin 86Bevacizumab 79Oxaliplatin 74Capecitabine 69tislelizumab 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 58pembrolizumab 56Specimen Handling 54sintilimab 53Surgical Procedures, Operative 52anlotinib 51Magnetic Resonance Spectroscopy 50Fluorouracil 49Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35Leucovorin 34lenvatinib 33venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Health Personnel × Clear all
NCT06965608 2025-05-11

FLACC-Brazil

Hospital Israelita Albert Einstein

Phase NA Not yet recruiting
1,200 enrolled
Tumor-Agnostic

Neoplasms

NCT06592430 2024-09-19

The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer Patietns

Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting
2,000 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡